• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Hypoallergenic Cats Could Be On The Horizon Thanks To New Genetic Discovery

December 5, 2024 by Deborah Bloomfield

Whether they’re trekking 1,450 kilometers (900 miles) or discovering new viruses, cats are pretty great. Unless, of course, you’re allergic. But what if there was a way to create felines that don’t leave your throat feeling akin to sandpaper? It’s early days, but new research into the protein that triggers allergies to cats has hinted at a potential gene editing target that could eventually give us hypoallergenic cats.

Approximately 15 percent of the US population is allergic to cats, experiencing symptoms including coughing, sneezing, irritated eyes, and asthma, which can range from mild to severe. Around 500,000 asthma attacks per year and 350,000 emergency care visits have been attributed to cat allergic disease, and yet, little is known about the diversity of the allergen that causes it or how it evolved.

Advertisement

There are several cat proteins known to induce an allergic response, the major one being Fel d 1, which is produced by all cats regardless of their breed, hair length, sex, age, or body weight. Cats produce Fel d 1 in their sebaceous, salivary, perianal, and lachrymal glands – contrary to common belief it is not the hair itself that causes allergies, but Fel d 1 on the hair. Different cats will produce different levels of the protein, meaning that some are more allergenic than others. However, as things stand, there are no cats that are completely hypoallergenic.

Fel d 1 is formed of two chains, and there are two genes, called CH1 and CH2, which encode each chain respectively. Its biological function is currently unknown, but research into similar proteins in other mammals suggests the allergen may be involved in immune regulation, protection of the epithelium, or chemical communication among cats.

In the new study, researchers compared Fel d1 sequences among 276 exotic and domestic cat species across millions of years of evolution, finding that they were variable along each evolutionary lineage. In fact, the team identified over 100 unique mutations in the protein sequence and found that CH1 and CH2 genes are also highly variable, which suggests the function of Fel d 1 could vary among cat species, or that Fel d 1 may not be essential for cats.

This was bolstered by the discovery that two cats – a cougar and a black-footed cat from Southern Africa – had natural mutations that significantly impair Fel d 1 protein. There has also been recent evidence of healthy cats with CRISPR-edited CH2.

Advertisement

So what does all this have to do with hypoallergenic cats? If our feline friends can do without Fel d 1, then we may be able to engineer happy, healthy cats without it – cats that, consequently, won’t get our noses running.

“The results suggest that Fel d 1 is a viable target for gene deletion to develop Fel d 1-free cats,” the researchers explain. “Deleting or rendering the Fel d 1 genes nonfunctional could have therapeutic implications for cat allergy sufferers by removing the allergen from the source.”

Essentially, with a little bit of CRISPR tinkering to delete CH1 and CH2, you could create hypoallergenic cats.

Of course, we’re still a long way from seeing this come to fruition, but it’s a very promising avenue of research, especially for any unfortunate cat lovers plagued by allergies to their beloved pets.

Advertisement

The study is published in PNAS Nexus.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Cricket-Manchester test likely to be postponed after India COVID-19 case
  2. EU to attend U.S. trade meeting put in doubt by French anger
  3. Soccer-West Ham win again, Leicester and Napoli falter
  4. Lacking Company, A Dolphin In The Baltic Is Talking To Himself

Source Link: Hypoallergenic Cats Could Be On The Horizon Thanks To New Genetic Discovery

Filed Under: News

Primary Sidebar

  • This 12,000-Year-Old Artwork Shows An “Extraordinary” Moment In History And Human Creativity
  • World’s First Critically Endangered Penguin Directly Competes With Fishing Boats For Food
  • Parasitic Ant Queens Use Chemical Warfare To Incite Revolutions Against Reigning Queens
  • Data From Mars Lets ESA Predict 3I/ATLAS’s Path 10 Times More Precisely
  • A Massive Gold Deposit Worth $192 Billion Has Been Discovered As Prices Stay Sky High For 2025
  • See It For Yourself: Your Chance To See Interstellar Comet 3I/ATLAS Livestreamed This Week
  • A Woman Born Missing Most Of Her Brain Just Celebrated Her 20th Birthday. What Does That Mean?
  • When And Where Interstellar Objects Like 3I/ATLAS Are Most Likely To Hit Earth
  • Person In The US Infected With A Form Of Bird Flu Never Seen In Humans Before
  • Carl Sagan Left A Heartfelt Message For The First People To Set Foot On Mars
  • People Are Just Learning About A Key Feature Of The Statue Of Liberty That Everyone Forgets
  • Lupus Linked To Virus That Over 95 Percent Of Us Carry, First Radio Detection Received From Interstellar Object 3I/ATLAS, And Much More This Week
  • Why Do Cars Have Those Lines On The Rear Window?
  • SpaceX CEO Elon Musk Responds To Wild Speculation That 3I/ATLAS Is An Alien Spaceship
  • Did NASA’s Viking Mission Find Evidence Of Extant Life On Mars? It’s Not As Out There As It Sounds
  • World’s Oldest RNA Recovered From Baby Mammoth Beautifully Preserved In Permafrost For 40,000 Years
  • No Mining, No Machines – How The Future Of Technology Depends On Greener Mines
  • “It Was A Huge Surprise”: Dinosaur Eggs Were Speckled And Colorful, Just Like Birds’ Eggs
  • Meet The Peacock Spiders: Secretive, Small But Oh So Special
  • “Sudden Unexplained Death” In US Turns Out To Be World’s First Confirmed Death From Tick-Spread “Meat Allergy”
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version